On June 4, Hims & Hers Health rose 5.93% in regular trading, trading at $29.38/share, with trading volume of $235 million.

On the news front, the company officially announced the completion of its acquisition of Australian telehealth company Eucalyptus on June 2, which served as the primary catalyst for the rally. The acquisition expands Hims & Hers' footprint across Australia, Canada, Germany, and other international markets, consolidating its position as the world's largest consumer health platform. The deal also extends clinically validated weight management services into Germany and strengthens the company's overall health management portfolio.

To facilitate the transaction, a prior agreement modification introduced a covenant compliance grace period, providing operational flexibility during the initial integration phase. The strategic move significantly broadens the company's product and service range, positioning it for sustained international growth.

Within the Health Care Services sector, CVS Health up 3.18%, THE CIGNA GROUP up 4.88%, Guardant Health up 3.64%, Chemed up 2.07%, BrightSpring Health Services down 2.96%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)